Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating iron reduction as a treatment approach for diabetes and nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Effect of Obesity on Proton Pump Inhibitors [Phase 4]
Phase 4 trial assessing the effect of obesity on proton pump inhibitors in pediatric obesity and NAFLD with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women [Phase 1]
Phase 1 pharmacokinetic study evaluating vitamin E (tocopherol) absorption and biomarkers in normal-weight and obese women.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
This completed study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) evaluated the response to COV…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated the combination of dasatinib and quercetin for fibrotic non-alcoholic fatty liver disease (NA…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Semaglutide vs Sitagliptin [Phase 4]
Phase 4 clinical trial comparing semaglutide and sitagliptin in liver transplant recipients with diabetes and fatty liver disease. Enrollmen…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Vitamin E Dosing Study [Phase 2]
A Phase II trial evaluating different dosing regimens of vitamin E for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis has…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD [NA]
This clinical trial update examines whether a very low-calorie diet reduces liver fat and fibrosis in adults with obesity and nonalcoholic f…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE
A pediatric imaging trial using free-breathing MRI and MR elastography to quantify body composition and liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) [Phase 2]
Phase 2 study MK-6024-017 evaluating efinopegdutide in compensated cirrhosis due to nonalcoholic fatty liver disease and nonalcoholic steato…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes. [Phase 4]
A Phase 4 study comparing the effects of dapagliflozin versus empagliflozin on nonalcoholic fatty liver disease in patients with type 2 diab…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: MHT and Liver Function in Postmenopausal Women [NA]
A completed clinical trial investigated the impact of menopausal hormone therapy on liver function in postmenopausal women, with focus on no…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study [Phase 2]
Phase 2 RELIEF-NAFLD trial update evaluating lisinopril to prevent progression of non-alcoholic fatty liver disease and nonalcoholic steatoh…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) [Phase 2]
Phase 2 study of efinopegdutide in participants with precirrhotic nonalcoholic steatohepatitis (NAFLD/NASH) has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial studying ibutamoren for nonalcoholic fatty liver disease has completed and posted results. The study was sponsored by Massachu…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [NA]
The document reports an ongoing clinical trial at Taichung Veterans General Hospital evaluating a nutritional education program for metaboli…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial [Phase 2, Phase 3]
Clinical trial evaluating curcumin's effects on lipid, metabolic and hormonal profiles and liver morphology in women with PCOS and NAFLD; Ph…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Effect of Inspiratory Muscle Training on Diaphragm Muscle Thickness, Fatty Liver Density and Aerobic Capacity in Elderly Men: A Randomized Controlled Trial [NA]
Completed randomized controlled trial evaluating the impact of inspiratory muscle training on diaphragm thickness, liver fat density, and ae…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Alternate Day Fasting, Exercise, and NAFLD [NA]
Clinical trial evaluating alternate day fasting combined with exercise for non-alcoholic fatty liver disease and obesity has completed. Resu…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Effects of Intermittent Fasting on Fatty Liver Disease [NA]
A completed clinical trial evaluating intermittent fasting in patients with nonalcoholic fatty liver disease, focusing on thyroid hormone se…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy
This completed clinical trial investigates the impact of hepatic steatosis on survival after pancreaticoduodenectomy.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Effect of Inspiratory Muscle Training on Diaphragm and Ab-dominal Wall Muscle Thickness With Fatty Liver Density in Elderly Women: A Randomized Controlled Trial [NA]
This is a completed randomized controlled trial evaluating whether inspiratory muscle training affects diaphragm and abdominal wall muscle t…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [Phase 3]
Phase 3 study evaluating efruxifermin in adults with noninvasively diagnosed nonalcoholic steatohepatitis and nonalcoholic fatty liver disea…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis [Phase 2]
This clinical trial update reports results from a Phase 2 study evaluating the safety and efficacy of cotadutide given by subcutaneous injec…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease [NA]
A completed clinical trial update suggests that polycystic ovary syndrome may be a risk factor for developing non-alcoholic fatty liver dise…